Date Time | Announcment |
|---|---|
| Nov 14, 2025, 9:37 PM IST | Aurobindo Pharma - Completion Of US FDA Inspection At Unit II Of Eugia Pharma Specialities Ltd., Bhiwadi, A Wholly Owned Subs |
| Nov 14, 2025, 5:20 PM IST | Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Nov 14, 2025, 4:02 PM IST | Aurobindo Pharma - Classification Of US FDA Inspection At Unit-I Of Apitoria Pharma Private Limited, A Wholly Owned Subsidiar |
| Nov 11, 2025, 10:32 PM IST | Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Nov 06, 2025, 1:34 AM IST | Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Nov 06, 2025, 1:30 AM IST | Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Nov 06, 2025, 1:22 AM IST | Aurobindo Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Held On November 5, 2025 |
| Nov 04, 2025, 6:27 AM IST | Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Change in Management |
| Oct 30, 2025, 8:53 PM IST | Aurobindo Pharma - Clarification With Reference To Movement In Volume. |
| Oct 30, 2025, 8:12 PM IST | Aurobindo Pharma - Clarification sought from Aurobindo Pharma Ltd |